Description
Interventions in non-metastatic castration-resistant prostate cancer: earlier seems better
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: Interventions in non-metastatic castration-resistant prostate cancer: earlier seems better
€2.42
